// App-Quantinova.ai

: Circulating tumor (ct)-DNA alterations in advanced urothelial carcinoma: Association with outcomes and evolution with therapy.

Researchers

Presenter

  • Petros Grivas

Principal Investigators

  • Rebecca J Nagy

  • Gregory Russell Pond

  • Sumati Gupta

  • Jue Wang

  • Ulka N. Vaishampayan

  • Sumanta K. Pal

  • Mehmet Asim Bilen

  • Gurudatta Naik

  • Pooja Ghatalia

  • Dharmesh Gopalakrishnan

  • Pedro Barata

  • Richard B. Lanman

  • Amirali Talasaz

  • Guru Sonpavde

Medical Centers

  • Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • Guardant Health, Rewdwood City, CA

  • Ontario Clinical Oncology Group, Hamilton, ON, Canada

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

  • University of Arizona Cancer Center at DH-SJHMC, Phoenix, AZ

  • Karmanos Cancer Institute, Detroit, MI

  • City of Hope, Duarte, CA

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • University of Alabama at Birmingham, Birmingham, AL

  • Fox Chase Cancer Center, Philadelphia, PA

  • Cleveland Clinic Foundation, Cleveland, OH

  • The University of Alabama Birmingham Comprehensive Cancer Center, Birmingham, AL

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved